Objective:To evaluate the efficacy of montelukast sodium orally dissolving films combined with triple nebulization in the treatment of pediatric asthmatic bronchopneumonia.Methods:A total of 60 pediatric patients with...Objective:To evaluate the efficacy of montelukast sodium orally dissolving films combined with triple nebulization in the treatment of pediatric asthmatic bronchopneumonia.Methods:A total of 60 pediatric patients with asthmatic bronchopneumonia who visited the hospital from December 2021 to December 2024 were selected as samples and randomly divided into two groups.Group A received combined therapy with montelukast sodium orally dissolving films,while Group B received triple nebulization therapy.The time to symptom relief,serum inflammatory factors,and adverse reactions were compared between the two groups.Results:The duration of asthma,cough,and wheezing,as well as the length of hospital stay,were shorter in Group A than in Group B(P<0.05).The levels of C-reactive protein(CRP),white blood cell count(WBC),and serum amyloid A(SAA)were lower in Group A than in Group B(P<0.05).The incidence of adverse reactions was lower in Group A than in Group B(P<0.05).Conclusion:The combination therapy of montelukast sodium orally dissolving films and triple nebulization for pediatric asthmatic bronchopneumonia can effectively inhibit inflammation,shorten the duration of symptoms,and is safe and efficient.展开更多
This clinical study aimed to explore the therapeutic effect of recombinant human interferonα2b nebulization inhalation in the treatment of hand,foot,and mouth disease in children.Sixty-six patients were selected as t...This clinical study aimed to explore the therapeutic effect of recombinant human interferonα2b nebulization inhalation in the treatment of hand,foot,and mouth disease in children.Sixty-six patients were selected as the research subjects by the random sampling method and divided into a control group and an observation group.The patients in the control group were treated with ribavirin injection and oral lysine-inositol-vitamin B12 solution,while the patients in the observation group received the treatment of the control group combined with recombinant human interferonα2b nebulization inhalation.The clinical effects of the two groups were compared to determine the clinical efficacy of the two treatment plans.The total effective rates of treatment were 78.79%in the control group and 90.91%in the observation group.The research confirmed that the clinical effect of recombinant human interferonα2b nebulization inhalation in the treatment of hand,foot,and mouth disease in children is remarkable.It can significantly improve the symptoms of children with hand,foot,and mouth disease and is suitable for clinical application and promotion.展开更多
Preliminary experiments are carried out to characterize the droplets generated in two aerosol-generating health care procedures,i.e.taking nasopharyngeal aspirates（NPA）and nebulizer therapy.Glass slides and water-se...Preliminary experiments are carried out to characterize the droplets generated in two aerosol-generating health care procedures,i.e.taking nasopharyngeal aspirates（NPA）and nebulizer therapy.Glass slides and water-sensitive paper（WSP）are used to collect large droplets when taking NPA.Droplet stain-marks on glass slides are counted under a microscope,and then a size analysis is performed.During nebulizer therapy dust monitors are used to detect small droplets and droplet nuclei at different positions around the nebulizer and in the room.From the preliminary results it is found that taking NPA can stimulate coughing and generate large droplets.Nebulizers can generate more than tens of millions fine droplets ranging from 0.3 to 20 μm per minute,a large volume of which can escape from the holes on the nebulizer＇s facemask and disperse in the whole room.Droplets coagulate on the inner surface of the mask and the volunteer＇s face,suggesting a great possibility of drug solution contamination by patients＇ secretion during nebulizer therapy.展开更多
文摘Objective:To evaluate the efficacy of montelukast sodium orally dissolving films combined with triple nebulization in the treatment of pediatric asthmatic bronchopneumonia.Methods:A total of 60 pediatric patients with asthmatic bronchopneumonia who visited the hospital from December 2021 to December 2024 were selected as samples and randomly divided into two groups.Group A received combined therapy with montelukast sodium orally dissolving films,while Group B received triple nebulization therapy.The time to symptom relief,serum inflammatory factors,and adverse reactions were compared between the two groups.Results:The duration of asthma,cough,and wheezing,as well as the length of hospital stay,were shorter in Group A than in Group B(P<0.05).The levels of C-reactive protein(CRP),white blood cell count(WBC),and serum amyloid A(SAA)were lower in Group A than in Group B(P<0.05).The incidence of adverse reactions was lower in Group A than in Group B(P<0.05).Conclusion:The combination therapy of montelukast sodium orally dissolving films and triple nebulization for pediatric asthmatic bronchopneumonia can effectively inhibit inflammation,shorten the duration of symptoms,and is safe and efficient.
文摘This clinical study aimed to explore the therapeutic effect of recombinant human interferonα2b nebulization inhalation in the treatment of hand,foot,and mouth disease in children.Sixty-six patients were selected as the research subjects by the random sampling method and divided into a control group and an observation group.The patients in the control group were treated with ribavirin injection and oral lysine-inositol-vitamin B12 solution,while the patients in the observation group received the treatment of the control group combined with recombinant human interferonα2b nebulization inhalation.The clinical effects of the two groups were compared to determine the clinical efficacy of the two treatment plans.The total effective rates of treatment were 78.79%in the control group and 90.91%in the observation group.The research confirmed that the clinical effect of recombinant human interferonα2b nebulization inhalation in the treatment of hand,foot,and mouth disease in children is remarkable.It can significantly improve the symptoms of children with hand,foot,and mouth disease and is suitable for clinical application and promotion.
基金The Project of Research Grants Council of the HongKong Special Administrative Region(No.HKU7150/06)
文摘Preliminary experiments are carried out to characterize the droplets generated in two aerosol-generating health care procedures,i.e.taking nasopharyngeal aspirates（NPA）and nebulizer therapy.Glass slides and water-sensitive paper（WSP）are used to collect large droplets when taking NPA.Droplet stain-marks on glass slides are counted under a microscope,and then a size analysis is performed.During nebulizer therapy dust monitors are used to detect small droplets and droplet nuclei at different positions around the nebulizer and in the room.From the preliminary results it is found that taking NPA can stimulate coughing and generate large droplets.Nebulizers can generate more than tens of millions fine droplets ranging from 0.3 to 20 μm per minute,a large volume of which can escape from the holes on the nebulizer＇s facemask and disperse in the whole room.Droplets coagulate on the inner surface of the mask and the volunteer＇s face,suggesting a great possibility of drug solution contamination by patients＇ secretion during nebulizer therapy.
